FDA Inspection
Kyowa Hakko Bio Co., Ltd.Kyowa Hakko Bio Co., Ltd. – FDA Inspection, Apr 15, 2022
Record Details
This FDA Inspection record concerns Kyowa Hakko Bio Co., Ltd., with an inspection on April 15, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Kyowa Hakko Bio Co., Ltd.
- Inspection Date
- April 15, 2022
- Product Type
- Drugs
View Company Profile
ID · d8992d2f-ee12-4634-b4e5-120e15294e66
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1168226
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Kyowa Hakko Bio Co., Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 8, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 27, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kyowa Hakko Bio Co., Ltd.
- FDA Inspection 1253956 - 2024-09-20
- FDA Inspection 1111871 - 2019-11-08
- FDA Inspection 1031649 - 2017-09-08
- FDA Inspection 873726 - 2014-03-20
- FDA Inspection 753000 - 2011-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.